I-Human Advanced DDX Case Study: Margaret Wilson
– Progressive Dyspnea, Volume Overload, and Heart
Failure with Reduced Ejection Fraction in a 60-Year-
Old Female EXAM with Questions and Answers/Plus
a Rationale Updated 2026 A+/Instant Download PDF
EXAM COVERAGE
1. Clinical Presentation and Diagnostic Reasoning for Dyspnea
2. Pathophysiology of HFrEF and Compensatory Mechanisms
3. Interpretation of Diagnostic Testing (BNP, Echocardiogram, CXR)
4. Hemodynamic Assessment and Physical Examination Findings
5. Pharmacological Management Strategies (ACEi/ARBs, Beta-blockers, Diuretics)
6. Differential Diagnosis of Acute Decompensated Heart Failure
7. Management of Volume Overload and Electrolyte Balance
8. Evidence-Based Guidelines for Chronic Heart Failure
9. Patient Education, Lifestyle Modification, and Prognosis
10. Risk Stratification and Long-term Monitoring
1. A 60-year-old female presents with progressive dyspnea on exertion, orthopnea, and paroxysmal
nocturnal dyspnea. Physical examination reveals bilateral 2+ pitting edema and elevated jugular
venous pressure. Which of the following diagnostic markers is most specific for identifying acute
decompensated heart failure in this patient?
, A. Elevated troponin I levels
B. Elevated B-type natriuretic peptide (BNP) levels
C. Increased C-reactive protein (CRP)
D. Decreased serum creatinine
Answer: B
Rationale: BNP is released in response to ventricular stretch and volume overload, making it
highly sensitive for diagnosing heart failure. Troponin I is more indicative of acute myocardial
infarction, while CRP and creatinine are non-specific markers for inflammation and renal
function, respectively.
CORRECT ANSWER : B
2. During cardiac auscultation of Margaret Wilson, you identify an S3 gallop. What is the most
likely underlying hemodynamic explanation for this finding?
A. Increased ventricular filling pressure in a dilated, non-compliant ventricle
B. Turbulent flow across a calcified mitral valve
C. Atrial contraction against a stiff, hypertrophied ventricle
D. Rapid closure of the aortic valve during inspiration
Answer: A
Rationale: An S3 heart sound is a hallmark of ventricular volume overload and increased filling
pressure, often associated with systolic dysfunction. Option B describes mitral stenosis, C
describes an S4, and D is physiologically incorrect regarding the mechanics of S3.
CORRECT ANSWER : A
3. Which pharmacological agent should be initiated for a patient with HFrEF to improve long-term
survival and reverse cardiac remodeling by inhibiting the renin-angiotensin-aldosterone system?
A. Furosemide
B. Amlodipine
C. Lisinopril
D. Digoxin
, Answer: C
Rationale: ACE inhibitors like lisinopril are foundational therapy for HFrEF because they
inhibit the RAAS, reducing afterload and slowing cardiac remodeling. Furosemide is for
symptom relief only, amlodipine is not a first-line agent for HFrEF, and digoxin is used for
symptom management, not mortality reduction.
CORRECT ANSWER : C
4. A chest X-ray on the patient reveals cardiomegaly and Kerley B lines. What is the clinical
significance of these findings in the context of progressive dyspnea?
A. They indicate an acute infectious process like pneumonia
B. They confirm pulmonary venous congestion and interstitial edema
C. They are signs of primary pulmonary hypertension
D. They suggest chronic obstructive pulmonary disease (COPD) exacerbation
Answer: B
Rationale: Kerley B lines and cardiomegaly are classic radiographic indicators of elevated left
atrial pressure leading to pulmonary venous congestion. These findings do not support
pneumonia (which would show infiltrates), COPD (which shows hyperinflation), or primary
pulmonary hypertension without left heart signs.
CORRECT ANSWER : B
5. Which of the following baseline laboratory findings is a critical safety consideration before
initiating high-dose spironolactone therapy in a patient with heart failure?
A. Serum potassium levels
B. Liver function tests
C. Hemoglobin A1c
D. Thyroid-stimulating hormone
Answer: A
Rationale: Spironolactone is a potassium-sparing diuretic that carries a significant risk of
hyperkalemia, especially in patients with decreased renal function. While other tests may be
monitored in patients with comorbidities, potassium is the critical safety marker for this specific
medication class.
, CORRECT ANSWER : A
(Questions 6 through 100 follow the same structure...)
6. A patient with HFrEF is being titrated on a beta-blocker. Which clinical assessment is most
important to perform during each follow-up visit to ensure patient safety?
A. Assessment of heart rate and blood pressure
B. Monitoring of peripheral oxygen saturation
C. Auscultation of breath sounds for wheezing
D. Measurement of daily fasting blood glucose
Answer: A
Rationale: Beta-blockers are negative chronotropes and inotropes, which can cause
symptomatic bradycardia and hypotension if titrated too aggressively. While respiratory status is
important, HR and BP are the primary physiological parameters that determine tolerability of
beta-blocker therapy in heart failure.
CORRECT ANSWER : A
7. Which mechanism best explains the development of paroxysmal nocturnal dyspnea (PND) in
patients with severe left ventricular dysfunction?
A. Increased daytime intake of sodium-rich fluids
B. Increased venous return to the heart when in the recumbent position
C. Nocturnal decrease in endogenous catecholamines
D. Diurnal variations in pulmonary artery pressure
Answer: B
Rationale: When a patient is recumbent, blood that pools in the lower extremities during the day
returns to the central circulation, increasing preload beyond the failing heart's capacity. This
leads to acute pulmonary congestion. The other options do not represent the primary mechanism
of orthopnea or PND.
CORRECT ANSWER : B
– Progressive Dyspnea, Volume Overload, and Heart
Failure with Reduced Ejection Fraction in a 60-Year-
Old Female EXAM with Questions and Answers/Plus
a Rationale Updated 2026 A+/Instant Download PDF
EXAM COVERAGE
1. Clinical Presentation and Diagnostic Reasoning for Dyspnea
2. Pathophysiology of HFrEF and Compensatory Mechanisms
3. Interpretation of Diagnostic Testing (BNP, Echocardiogram, CXR)
4. Hemodynamic Assessment and Physical Examination Findings
5. Pharmacological Management Strategies (ACEi/ARBs, Beta-blockers, Diuretics)
6. Differential Diagnosis of Acute Decompensated Heart Failure
7. Management of Volume Overload and Electrolyte Balance
8. Evidence-Based Guidelines for Chronic Heart Failure
9. Patient Education, Lifestyle Modification, and Prognosis
10. Risk Stratification and Long-term Monitoring
1. A 60-year-old female presents with progressive dyspnea on exertion, orthopnea, and paroxysmal
nocturnal dyspnea. Physical examination reveals bilateral 2+ pitting edema and elevated jugular
venous pressure. Which of the following diagnostic markers is most specific for identifying acute
decompensated heart failure in this patient?
, A. Elevated troponin I levels
B. Elevated B-type natriuretic peptide (BNP) levels
C. Increased C-reactive protein (CRP)
D. Decreased serum creatinine
Answer: B
Rationale: BNP is released in response to ventricular stretch and volume overload, making it
highly sensitive for diagnosing heart failure. Troponin I is more indicative of acute myocardial
infarction, while CRP and creatinine are non-specific markers for inflammation and renal
function, respectively.
CORRECT ANSWER : B
2. During cardiac auscultation of Margaret Wilson, you identify an S3 gallop. What is the most
likely underlying hemodynamic explanation for this finding?
A. Increased ventricular filling pressure in a dilated, non-compliant ventricle
B. Turbulent flow across a calcified mitral valve
C. Atrial contraction against a stiff, hypertrophied ventricle
D. Rapid closure of the aortic valve during inspiration
Answer: A
Rationale: An S3 heart sound is a hallmark of ventricular volume overload and increased filling
pressure, often associated with systolic dysfunction. Option B describes mitral stenosis, C
describes an S4, and D is physiologically incorrect regarding the mechanics of S3.
CORRECT ANSWER : A
3. Which pharmacological agent should be initiated for a patient with HFrEF to improve long-term
survival and reverse cardiac remodeling by inhibiting the renin-angiotensin-aldosterone system?
A. Furosemide
B. Amlodipine
C. Lisinopril
D. Digoxin
, Answer: C
Rationale: ACE inhibitors like lisinopril are foundational therapy for HFrEF because they
inhibit the RAAS, reducing afterload and slowing cardiac remodeling. Furosemide is for
symptom relief only, amlodipine is not a first-line agent for HFrEF, and digoxin is used for
symptom management, not mortality reduction.
CORRECT ANSWER : C
4. A chest X-ray on the patient reveals cardiomegaly and Kerley B lines. What is the clinical
significance of these findings in the context of progressive dyspnea?
A. They indicate an acute infectious process like pneumonia
B. They confirm pulmonary venous congestion and interstitial edema
C. They are signs of primary pulmonary hypertension
D. They suggest chronic obstructive pulmonary disease (COPD) exacerbation
Answer: B
Rationale: Kerley B lines and cardiomegaly are classic radiographic indicators of elevated left
atrial pressure leading to pulmonary venous congestion. These findings do not support
pneumonia (which would show infiltrates), COPD (which shows hyperinflation), or primary
pulmonary hypertension without left heart signs.
CORRECT ANSWER : B
5. Which of the following baseline laboratory findings is a critical safety consideration before
initiating high-dose spironolactone therapy in a patient with heart failure?
A. Serum potassium levels
B. Liver function tests
C. Hemoglobin A1c
D. Thyroid-stimulating hormone
Answer: A
Rationale: Spironolactone is a potassium-sparing diuretic that carries a significant risk of
hyperkalemia, especially in patients with decreased renal function. While other tests may be
monitored in patients with comorbidities, potassium is the critical safety marker for this specific
medication class.
, CORRECT ANSWER : A
(Questions 6 through 100 follow the same structure...)
6. A patient with HFrEF is being titrated on a beta-blocker. Which clinical assessment is most
important to perform during each follow-up visit to ensure patient safety?
A. Assessment of heart rate and blood pressure
B. Monitoring of peripheral oxygen saturation
C. Auscultation of breath sounds for wheezing
D. Measurement of daily fasting blood glucose
Answer: A
Rationale: Beta-blockers are negative chronotropes and inotropes, which can cause
symptomatic bradycardia and hypotension if titrated too aggressively. While respiratory status is
important, HR and BP are the primary physiological parameters that determine tolerability of
beta-blocker therapy in heart failure.
CORRECT ANSWER : A
7. Which mechanism best explains the development of paroxysmal nocturnal dyspnea (PND) in
patients with severe left ventricular dysfunction?
A. Increased daytime intake of sodium-rich fluids
B. Increased venous return to the heart when in the recumbent position
C. Nocturnal decrease in endogenous catecholamines
D. Diurnal variations in pulmonary artery pressure
Answer: B
Rationale: When a patient is recumbent, blood that pools in the lower extremities during the day
returns to the central circulation, increasing preload beyond the failing heart's capacity. This
leads to acute pulmonary congestion. The other options do not represent the primary mechanism
of orthopnea or PND.
CORRECT ANSWER : B
